Drug Management of Prostate Cancer
This book is a comprehensive, concise summary of the pharmacological treatments of prostate cancer. It is an authoritative and up-to-date reference on therapeutic options involving both standard of care and investigational agents. The chapters describe state of the art information on Hormone Therapy...
| Corporate Author: | |
|---|---|
| Other Authors: | , , |
| Format: | Electronic |
| Language: | English |
| Published: |
New York, NY :
Springer New York : Imprint: Springer,
2010.
|
| Subjects: | |
| Online Access: | https://ezaccess.library.uitm.edu.my/login?url=http://dx.doi.org/10.1007/978-1-60327-829-4 |
Table of Contents:
- Section One: Hormone Therapy
- Cell Biology of Prostate Cancer and Molecular Targets
- Luteinizing Hormone-Releasing Hormone (Lh-Rh) and its Agnostic, Antagonistic and Targeted Cytotoxic Analogs in Prostate Cancer
- Nuclear Receptor Coregulators: Promising Therapeutic Targets for the Treatment of Prostate Cancer
- Androgens and Prostate Cancer
- Androgen Receptor Biology in Prostate Cancer
- Androgen Receptor Antagonists
- 5 alpha Reductase Inhibitors in Prostate Cancer
- Adrenolytic Therapies in Castration Resistant Prostate Cancer
- Androgen Deprivation Therapy
- Pharmacogenetics of the Androgen Metabolic Pathway
- Section Two: Chemotherapy
- Mitoxantrone
- Docetaxel
- Beyond Docetaxel: Emerging Agents in the Treatment of Advanced Prostate Cancer
- Platinum Agents in Prostate Cancer
- Clinical Pharmacology and Pharmacogenetics of Chemotherapy in Prostate Cancer
- Microtubule Targeting Agents
- Section Three: Angiogenesis
- Principles of Antiangiogenic Therapy
- Bevacizumab in Advanced Prostate Cancer
- Thalidomide and Analogs
- Investigational Angiogenesis Inhibitors
- Pharmacogenetics of Angiogenesis
- Section Four: Bone Metastasis
- Pathophysiology of Prostate Cancer Bone Metastasis
- Radiopharmaceuticals
- Bisphosphonates for Prevention and Treatment of Bone Metastases
- Endothelin Receptors as Therapeutic Targets in Castrate Resistant Prostate Cancer
- Calcitriol and Vitamin D Analogs
- Cancer Immunology, Immunotherapeutics and Vaccine Approaches
- Sipuleucel-T (APC8015): Active Cellular Immunotherapy for Advanced Metastatic Castrate-Resistant Prostate Cancer
- GM-CSF Genes Transduced Prostate Cancer Vaccines: GVAX
- CTLA-4 Blockade for Prostate Cancer Treatment
- Section Five: Prevention
- Prostate Cancer Chemoprevention Strategies
- Diet and Prostate Cancer Incidence, Recurrence, and Progression Risk
- Inflammation as a Target in Prostate Cancer
- Section Six: Drug Development
- Challenges for the Development of New Agents in Prostate Cancer
- FDA Approval of Prostate Cancer Treatments
- Applications of Proteomics in Prostate Cancer.